Terms: = Prostate cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6 AND Treatment
6 results:
1. Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide versus apalutamide for the treatment of nonmetastatic castration-resistant prostate cancer.
Tombal B; Sternberg CN; Hussain M; Ganguli A; Li Y; Sandin R; Bhadauria H; Oh M; Saad F
ESMO Open; 2022 Jun; 7(3):100510. PubMed ID: 35714477
[TBL] [Abstract] [Full Text] [Related]
2. TGFβ signaling limits lineage plasticity in prostate cancer.
Hao Y; Bjerke GA; Pietrzak K; Melhuish TA; Han Y; Turner SD; Frierson HF; Wotton D
PLoS Genet; 2018 May; 14(5):e1007409. PubMed ID: 29782499
[TBL] [Abstract] [Full Text] [Related]
3. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.
Jackson RS; Placzek W; Fernandez A; Ziaee S; Chu CY; Wei J; Stebbins J; Kitada S; Fritz G; Reed JC; Chung LW; Pellecchia M; Bhowmick NA
Neoplasia; 2012 Jul; 14(7):656-65. PubMed ID: 22904682
[TBL] [Abstract] [Full Text] [Related]
4. Transcriptional regulatory networks in human lung adenocarcinoma.
Meng X; Lu P; Bai H; Xiao P; Fan Q
Mol Med Rep; 2012 Nov; 6(5):961-6. PubMed ID: 22895549
[TBL] [Abstract] [Full Text] [Related]
5. Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.
Yamashita S; Takahashi S; McDonell N; Watanabe N; Niwa T; Hosoya K; Tsujino Y; Shirai T; Ushijima T
Cancer Res; 2008 Apr; 68(7):2112-21. PubMed ID: 18381416
[TBL] [Abstract] [Full Text] [Related]
6. Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy.
Beer TM; Myrthue A; Garzotto M; O'hara MF; Chin R; Lowe BA; Montalto MA; Corless CL; Henner WD
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2225-32. PubMed ID: 15598784
[TBL] [Abstract] [Full Text] [Related]
